I believe purified red wine molecules may improve the structure and function of the living retina, and I provide a scientific case report to support my contention.
I urge you, if you have wet macular degeneration, to speak with your eye physician.
The dietary supplement used in this study is not for everyone - for example, children, pre-menopausal females, those who are anemic --- learn more.
~ Stuart P. Richer OD, PhD
From: The Association for Research in Vision & Ophthalmology (ARVO) annual meeting, Fort Lauderdale, Fla.,
Ft. Lauderdale, FL (May 6, 2012) – There may be new found hope for patients whose vision is threatened when medicine injected directly into the eyes fails to cause abnormal blood vessels to recede. While injectable drugs called angiogenesis (an-gee-oh-jen-esis) inhibitors are considered a modern miracle and have become the standard of care for patients with the fast-progressive form of macular degeneration, they are not foolproof. For the first time researchers report that an oral nutriceutical, used on a last-resort clinical basis, rapidly restores vision to otherwise hopeless patients who face permanent loss.
Stuart Richer OD, PhD, Director, Ocular Preventative Medicine-Eye Clinic, James A. Lovell Federal Health Care Center, North Chicago, Illinois, says all other therapies were exhausted before employing the oral nutriceutical under compassionate-use protocols on a case-by-case basis. Usually most patients respond to medicine injected directly into the eyes, he says, but only about one in three patients recover driving vision and one in six patients go on to experience permanent vision loss and others may refuse needle injections directly into the eyes, making them candidates for this rescue medicine.
Three successfully treated cases were presented at the annual Association for Research in Vision & Ophthalmology meeting in Ft. Lauderdale, Florida.
One striking case is an 88-year old woman whom retinal specialists said was beyond any help offered by conventional medicines or surgery. The nutriceutical helped this hospitalized woman regain her ability to see faces, read a menu and visualize her handwriting in just 4 days. “As she was an in-patient, we noted that curiously that her systemic hypotension and 40 year history of migraines improved over the coming months of use”, according to Dr Richer.
In another case a 75-year old man with failing vision experienced recovery of vision in 5 days and was able to renew his driver’s license after taking just 7 nutriceutical capsules.
Dr. Richer says 16 of the first 17 cases responded positively to nutriceutical medicine. There were no side effects reported. Because these patients faced impending loss of vision, for ethical reasons no patients received inactive placebo pills. He says it is unknown whether this nutriceutical produces such positive results in the more common dry form of macular degeneration, but the benefit to vision is typically bilateral (both eyes) and self-evident.
Dr. Richer says in these first cases he has monitored, blind spots (called scotomas) disappear, time to recover from bright light (glare recovery test) is reduced, and contrast vision (shades of grey) as well as visual acuity (ability to see letters on a chart) generally improve within 3-6 weeks with the nutriceutical. “With our instruments we documented a more youthful appearance of the individual retinal layers, as well as the underlying circulation. “There were also these systemic improvements in some patients that were unanticipated.”
Only in recent years has there been a reliable way to treat wet macular degeneration, a disorder where abnormal blood vessels invade the visual center (macula) of the eyes. Any of three FDA-approved drugs, Avastin, Lucentis and Eylea, are needle-injected into the white of the eye to diminish the formation of these abnormal blood vessels. These are considered miracle drugs. Re-treatment is usually necessary every six to eight weeks. However, since these drugs are not foolproof, an oral formulation was employed with measurable success.
Dr. Richer selected a particular nutriceutical mixture of vitamins and small herbal molecules (Longevinex®) because of its extensive testing, publications and its proven ability to favorably alter genes in a superior manner to other available nutriceuticals. Dr. Richer cautions that other similar store-bought products are not likely to produce the same rapid results seen among his patients. He advises patients not to risk their vision with unproven products. Nor should patients consider this oral medicine supplants injected medicine.
While the nutriceutical used in this report is non-prescription and directly available to patients and could be used alongside injected drugs, Dr. Richer advises physician consultation prior to its use. “It still remains unproven until it is evaluated in broader studies” says Dr. Richer who adds: “the new science of epi-genetics suggests that age-related eye problems may not be inevitably progressive and biological age is not necessarily cast in stone.” There is new-found hope for recovery of lost vision, regardless of the patient’s age.